Haven Capital Group Inc. Purchases Shares of 6,171 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Haven Capital Group Inc. purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 6,171 shares of the medical equipment provider’s stock, valued at approximately $3,221,000. Intuitive Surgical accounts for approximately 3.0% of Haven Capital Group Inc.’s holdings, making the stock its 13th largest holding.

Several other institutional investors have also added to or reduced their stakes in ISRG. Atala Financial Inc purchased a new stake in Intuitive Surgical during the 4th quarter valued at $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth about $31,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the 3rd quarter worth about $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $488.80 on Tuesday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market capitalization of $174.10 billion, a P/E ratio of 76.26, a P/E/G ratio of 5.85 and a beta of 1.43. The firm’s 50 day simple moving average is $566.38 and its two-hundred day simple moving average is $531.96.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now owns 3,282 shares of the company’s stock, valued at $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

ISRG has been the subject of several research analyst reports. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Leerink Partners raised their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Bernstein Bank raised their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. BTIG Research raised their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Finally, Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $610.19.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.